Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Babjuk

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
BJU International|April 16, 2024
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancerEkaterina Laukhtina, Paolo Gontero, Marko Babjuk, et al.
European Urology Oncology|June 19, 2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer GroupWei Shen Tan, Gary Steinberg, J Alfred Witjes, et al.
The Journal of Urology|October 23, 2012
Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancerMichael Rink, Evanguelos Xylinas, Marko Babjuk, et al.
European Urology|June 22, 2016
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016Marko Babjuk, Andreas Böhle, Maximilian Burger, et al.
Nature Reviews. Urology|June 16, 2021
100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19Niyati Lobo, Nathan A Brooks, Alexandre R Zlotta, et al.
European Urology|September 18, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladderMaximilian Burger, Willem Oosterlinck, Badrinath Konety, et al.
World Journal of Urology|September 9, 2016
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, Shahrokh F Shariat, Seth P Lerner, et al.
World Journal of Urology|December 5, 2019
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancerShoji Kimura, David D'Andrea, Takehiro Iwata, et al.
Urologic Oncology|November 15, 2020
Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, David D Andrea, Fahad Quhal, et al.
European Urology Focus|July 21, 2017
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysisIlaria Lucca, Patrice Jichlinski, Shahrokh F Shariat, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
BJU International|April 16, 2024
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder cancerEkaterina Laukhtina, Paolo Gontero, Marko Babjuk, et al.
European Urology Oncology|June 19, 2022
Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer GroupWei Shen Tan, Gary Steinberg, J Alfred Witjes, et al.
The Journal of Urology|October 23, 2012
Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancerMichael Rink, Evanguelos Xylinas, Marko Babjuk, et al.
European Urology|June 22, 2016
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016Marko Babjuk, Andreas Böhle, Maximilian Burger, et al.
Nature Reviews. Urology|June 16, 2021
100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19Niyati Lobo, Nathan A Brooks, Alexandre R Zlotta, et al.
European Urology|September 18, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladderMaximilian Burger, Willem Oosterlinck, Badrinath Konety, et al.
World Journal of Urology|September 9, 2016
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, Shahrokh F Shariat, Seth P Lerner, et al.
World Journal of Urology|December 5, 2019
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancerShoji Kimura, David D'Andrea, Takehiro Iwata, et al.
Urologic Oncology|November 15, 2020
Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladderVictor M Schuettfort, David D Andrea, Fahad Quhal, et al.
European Urology Focus|July 21, 2017
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysisIlaria Lucca, Patrice Jichlinski, Shahrokh F Shariat, et al.
Pageof 12